tiprankstipranks
Trending News
More News >
Sienna Biopharmaceuticals (SNNAQ)
OTHER OTC:SNNAQ
US Market

Sienna Biopharmaceuticals (SNNAQ) Income Statement

Compare
71 Followers

Sienna Biopharmaceuticals Income Statement

Last quarter (Q3 2019), Sienna Biopharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Sienna Biopharmaceuticals's net income was $-3.97M. See Sienna Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -157.00K
Operating Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ 76.50M
Depreciation and Amortization
$ 228.49K$ 236.56K$ 206.30K$ 171.86K$ 157.00K
EBITDA
$ 0.00$ 0.00$ 0.00$ 0.00$ -76.34M
Operating Income
$ 0.00$ 0.00$ 0.00$ 0.00$ -76.50M
Other Income/Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ 3.03M
Pretax Income
$ 0.00$ 0.00$ 0.00$ 0.00$ -73.47M
Net Income
$ 0.00$ 0.00$ 0.00$ 0.00$ -73.31M
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ -3.59
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ -3.59
Weighted Average Shares Outstanding
30.73M 30.73M 30.73M 30.73M 20.45M
Weighted Average Shares Outstanding (Diluted)
30.73M 30.73M 30.73M 30.73M 20.45M
Currency in USD

Sienna Biopharmaceuticals Earnings and Revenue History